In an oral presentation today, the company shared continued progress in increasing the diversity of participants enrolled in the BASECAMP-1 nationwide prescreening study for all Tmod™ CAR T-cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback